Previous Article | Next Article ![]()
Infection and Immunity, December 1998, p. 5620-5629, Vol. 66, No. 12
Department of Microbiology, Medicine Research
Centre, Glaxo Wellcome S.p.A., 37100 Verona,
Italy,1 and
Geneva Biomedical
Research Institute, Glaxo Wellcome, Geneva,
Switzerland2
Received 6 May 1998/Returned for modification 22 June 1998/Accepted 18 August 1998
Streptococcus pneumoniae is the major cause of
bacterial pneumonia, and it is also responsible for otitis
media and meningitis in children. Apart from the capsule, the
virulence factors of this pathogen are not completely understood.
Recent technical advances in the field of bacterial pathogenesis (in
vivo expression technology and signature-tagged mutagenesis [STM])
have allowed a large-scale identification of virulence genes. We have
adapted to S. pneumoniae the STM technique, originally used
for the discovery of Salmonella genes involved in
pathogenicity. A library of pneumococcal chromosomal fragments (400 to
600 bp) was constructed in a suicide plasmid vector carrying
unique DNA sequence tags and a chloramphenicol resistance marker. The
recent clinical isolate G54 was transformed with this library.
Chloramphenicol-resistant mutants were obtained by homologous
recombination, resulting in genes inactivated by insertion of the
suicide vector carrying a unique tag. In a mouse pneumonia model, 1.250 candidate clones were screened; 200 of these were not recovered from
the lungs were therefore considered virulence-attenuated mutants. The
regions flanking the chloramphenicol gene of the attenuated mutants
were amplified by inverse PCR and sequenced. The sequence analysis
showed that the 200 mutants had insertions in 126 different genes that
could be grouped in six classes: (i) known pneumococcal virulence
genes; (ii) genes involved in metabolic pathways; (iii) genes encoding
proteases; (iv) genes coding for ATP binding cassette transporters; (v)
genes encoding proteins involved in DNA recombination/repair; and (vi)
DNA sequences that showed similarity to hypothetical genes with unknown
function. To evaluate the virulence attenuation for each mutant, all
126 clones were individually analyzed in a mouse septicemia model. Not all mutants selected in the pneumonia model were confirmed in
septicemia, thus indicating the existence of virulence factors specific
for pneumonia.
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Large-Scale Identification of Virulence Genes from
Streptococcus pneumoniae
*
Corresponding author. Mailing address: Glaxo Wellcome
S.p.A., Microbiology Department, via A. Fleming 4, 37135 Verona,
Italy. Phone: (39) 45 9218554. Fax: (39) 45 9218196. E-mail:
ds20886{at}glaxowellcome.co.uk.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|